Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: A randomized multicentre trial

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 1, 2001, Pages 123-128

  Petroni, M L ^a   Jazrawi, R P ^a   Pazzi, P ^b   Lanzini, A ^c   Zuin, M ^d   Pigozzi, M G ^c   Fracchia, M ^e   Galatola, G ^e   Alvisi, V ^b   Heaton, K W ^f   Podda, M ^d   Northfield, T C ^a,g  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b S ANNA HOSPITAL   (Italy)

^c SPEDALI CIVILI   (Italy)

^d Istituto Scienze Biomediche S Paolo   (Italy)

^e MAURIZIANO HOSPITAL   (Italy)

^f BRISTOL ROYAL INFIRMARY   (United Kingdom)

^g ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHENODEOXYCHOLIC ACID; CHOLESTEROL; LIPID; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHOLECYSTOGRAPHY; CHOLESTEROL STONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; GALLSTONE DISSOLUTION; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; CHENODEOXYCHOLIC ACID; CHOLELITHIASIS; CHOLESTEROL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SOLUBILITY; URSODEOXYCHOLIC ACID;

EID: 0035176575     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00853.x     Document Type: Article

References (26)

1. Patients selection for bile acid therapy
2. Comparative effect of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in man. Evidence for different modes of action on bile acid synthesis
3. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid in biliary lipid secretion and bile acid synthesis in patients with gallstones
4. Effect of different doses of chenodeoxycholic acid on bile lipid composition and on frequency of side effects in patients with gallstones
5. Chenotherapy for gallstone dissolution: I. Efficacy and safety
6. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis
7. Optimum bile acid therapy for rapid gallstone dissolution
8. A combination of ursodeoxycholic acid and chenodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation
9. Dissolution of human cholesterol gallstones in stimulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. An in vitro study of dissolution rates and mechanisms
10. Mesophase formation during cholesterol dissolution in ursodeoxycholiclecithin solutions: New mechanisms for cholesterol dissolution in humans
11. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones
12. Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones
13. Ursodeoxycholic acid treatment in cholesterol gallstone disease: Effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, bilairy lipid composition, and plasma lipid levels
14. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon
15. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes
16. Effects of bile acids on human hepatic mitochondria
17. Ursodeoxycholic acid and gallstone calcification
18. Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid
19. Retrospective comparison of 'cheno' and `urso' in the medical treatment of gallstones
20. Efficacy and safety of a combination of chenodeoxycholic and ursodeoxycholic acid for gallstone dissolution: A comparison with ursodeoxycholic acid alone
21. Dissolution of gallstones using ursodeoxycholic acid with or without chenodeoxycholic acid or taurine
22. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acid. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool and serum lipids
23. Combination treatment with different doses of urso (U) and chenodeoxycholic acid (C) in patients with cholesterol gallstones
24. Efficacy of combined ursodeoxycholic and chenodeoxycholic acid treatment
25. Characteristics of recurrent gallstones following non-surgical treatment: Implication for retreatment
26. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: Comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid